+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05791162

Study of Follicular Helper and Regulatory T Cell Ratios to Predict Disease Progression in IgA Nephropathy

Led by Centre Hospitalier Universitaire de Besancon · Updated on 2024-11-21

75

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the ratio of Follicular helper T cells to Follicular regulatory T cells TfhTfr in people with IgA nephropathy, a kidney condition. The study aims to find differences in this ratio between patients whose disease is stable and those whose disease progresses. It also seeks to predict how the disease will evolve within the first year after diagnosis. The study includes three groups patients diagnosed with IgA nephropathy since 2009 who have been followed for at least 5 years, patients newly diagnosed during the study, and control patients with other kidney diseases like Lupus, ANCA-associated vasculitis, or polycystic kidney disease. Blood and urine samples are collected at various points, including at study entry, during relapse, at treatment start, and at 3 and 6 months after diagnosis. Participants will have blood and urine collected multiple times depending on their group to analyze the TfhTfr ratio and other markers. Researchers will monitor the disease form stable or progressive over 12 months to understand clinical outcomes. The study runs until May 2026, with assessments focused on early prediction of disease progression using these biological markers.

CONDITIONS

Brief Title

Interest of Follicular Helper Lymphocytes / Regulatory Follicular Helper Lymphocytes Ratio in IgA Nephropathy

Research Team

C

Charline Vauchy, PhD.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here